Showing posts with label future publishing. Show all posts
Showing posts with label future publishing. Show all posts

Saturday, April 4, 2015

More on Brazilian science

I have been sent some interesting links recently about problems in Brazilian academia. 
  • Mauricio Tuffani, a journalist with Folha de S. Paulo, a Brazilian daily newspaper, has been publishing on some troubling situations in Brazilian academia. I just  blogged about an article he wrote about the government recommending mock conferences. He has written about academics inflating their CVs with conference papers given at a Chinese conference now appearing as peer-reviewed journal articles (one even already published in December 2015 [that is, 8 months in the future]) and the triennial report ranking graduate study institutions includes thousands of articles published by Brazilian academics in 201 predatory journals from 11 publishers. He lists the journals here. After he revealed that the Pakistani publisher of a predatory journal that also practices future publishing was not, in fact, a professor, the name disappeared from the web page. He reports on the deafening silence that can be heard from Brazilian academia here.
  • Retraction watch reports on retractions of a number of chemistry papers from a Brazilian journal.
  • The editor of the journal of the  Instituto Israelita de Ensino e Pesquisa Albert Einstein [Einstein (Sao Paulo). 2014 Oct-Dec;12(4):vii-viii. doi: 10.1590/S1679-45082014ED3296.] writes in an editorial entitled Scientific Misconduct - Our first (known) case:
    A recent paper by Lins and Carvalho (2) analyzed scientific misconduct in Brazil. They found a clear increase in both published articles in the medical literature and cases of scientific misconduct, including irreproducible results, “scientific salami slicing” (one article fragmented into 10 or more papers) and duplicate publications. In Lins and Carvalho’s opinion, the increased number of Brazilian scientific productions in medical literature was not accompanied by an increase in quality of articles – just the opposite. The authors discuss the focus of Brazilian institutional review boards in patient safety, within institutions themselves and the Brazilian National Review Board. Neither group performs a systematic surveillance for research integrity, and no specific offices exist to investigate and deal with scientific misconduct.
    (2) Lins L, Carvalho FM. Scientific integrity in Brazil. J Bioeth Inq. 2014;11(3):283-7.